Rationale for a metabolic approach in diabetic coronary patients
- 1 November 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 16 (Supplement) , S11-S15
Abstract
The incidence of ischaemic heart disease and acute myocardial infarction are greater in people with diabetes than in nondiabetic individuals. Heart disease patients with diabetes have a higher incidence of mortality during and following an acute myocardial infarction and a high risk for progression to heart failure post-infarction. The greater occurrence of ischaemic heart disease is partially due to a poorer coronary artery disease risk factor profile in diabetic patients, and, importantly, due to diabetes-induced abnormalities in the myocardium, termed ‘diabetic cardiomyopathy’. The main metabolic abnormalities in the diabetic myocardium are impaired carbohydrate metabolism, specifically reduced pyruvate oxidation in the mitochondria and a greater reliance on fatty acids and ketone bodies as fuels. The healthy heart takes up glucose and lactate and converts them to pyruvate; however, in the diabetic heart there is a reduced capacity to oxidize pyruvate, and thus less glucose and lactate uptake. The defective metabolism is due to high circulating free fatty acids and ketone body concentrations in the plasma, resulting in greater acetyl-Co-enzyme A/Co-enzyme A and reduced nicotinamide adenonine dinucleotide/nicotinamide adenonine dinucleotide+ ratios in the mitochondria, and the subsequent inhibition of pyruvate dehydrogenase. Pharmacological inhibition of fatty acid oxidation during ischaemia increases myocardial pyruvate oxidation and provides clinical benefit to patients with stable angina or ischaemic left ventricular dysfunction. Recent clinical trials with trimetazidine, an inhibitor of the fatty acid β-oxidation enzyme long chain 3-ketoacylthiolase, showed improvement in cardiac function and exercise performance in diabetic patients with ischaemic heart disease, illustrating the effectiveness of this approach in diabetes.Keywords
This publication has 33 references indexed in Scilit:
- Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial InfarctionCirculation, 2004
- Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularizationJACC, 2004
- Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial InfarctionCirculation, 2002
- Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial InfarctionCirculation, 2000
- An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffnessProceedings of the National Academy of Sciences, 2000
- Regulation of energy substrate metabolism in the diabetic heartCardiovascular Research, 1997
- The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosisJACC, 1989
- The Impact of Diabetes on Survival Following Myocardial Infarction in Men vs WomenJAMA, 1988
- Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning.Journal of Clinical Investigation, 1986
- Diabetes and Cardiovascular DiseaseJAMA, 1979